This inventor holds 1 USPTO granted patent. Top assignee: Carnegie Mellon University. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Daiwon Chol
Introduction
Daiwon Chol is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of materials science, particularly in the development of nanocrystalline hydroxyapatite particles. His work has implications for various applications, including tissue engineering.
Latest Patents
Daiwon Chol holds a patent titled "Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids." This patent describes a method for producing nanocrystalline hydroxyapatite particles. The particles produced exhibit substantially superior cell transformation abilities compared to known and commercially available calcium phosphate kits. Additionally, these nanocrystalline hydroxyapatite particles are useful in tissue engineering applications, such as bone and tooth engineering and repair.
Career Highlights
Daiwon Chol is affiliated with Carnegie Mellon University, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential to advance medical and engineering practices.
Collaborations
Daiwon Chol collaborates with esteemed colleagues, including Prashant Nagesh Kumta and Charles S Sfeir. Their combined expertise enhances the research and development efforts at Carnegie Mellon University.
Conclusion
Daiwon Chol's contributions to the field of materials science, particularly through his patent on nanocrystalline hydroxyapatite, highlight his innovative spirit and dedication to advancing technology. His work continues to influence the future of tissue engineering and related applications.